NasdaqGM - Delayed Quote USD

VanEck Biotech ETF (BBH)

155.59 +0.82 (+0.53%)
At close: April 26 at 4:00 PM EDT
152.86 -2.79 (-1.79%)
After hours: April 26 at 4:05 PM EDT
Key Events
Loading Chart for BBH
DELL
  • Previous Close 154.77
  • Open 154.55
  • Bid 154.29 x 200
  • Ask 162.61 x 100
  • Day's Range 154.55 - 156.17
  • 52 Week Range 142.51 - 171.05
  • Volume 6,386
  • Avg. Volume 7,803
  • Net Assets 452.51M
  • NAV 155.66
  • PE Ratio (TTM) 15.75
  • Yield 0.43%
  • YTD Daily Total Return -5.88%
  • Beta (5Y Monthly) 0.85
  • Expense Ratio (net) 0.35%

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

VanEck

Fund Family

Health

Fund Category

452.51M

Net Assets

2011-12-20

Inception Date

Performance Overview: BBH

Trailing returns as of 4/26/2024. Category is Health.

YTD Return

BBH
5.88%
Category
6.33%
 

1-Year Return

BBH
0.95%
Category
11.04%
 

3-Year Return

BBH
6.31%
Category
0.38%
 

People Also Watch

Holdings: BBH

Top 10 Holdings (68.04% of Total Assets)

SymbolCompany% Assets
AMGN
Amgen Inc. 14.81%
VRTX
Vertex Pharmaceuticals Incorporated 9.40%
GILD
Gilead Sciences, Inc. 8.06%
REGN
Regeneron Pharmaceuticals, Inc. 7.74%
MRNA
Moderna, Inc. 5.36%
IQV
IQVIA Holdings Inc. 4.93%
ILMN
Illumina, Inc. 4.46%
ICLR
ICON Public Limited Company 4.45%
ARGX
argenx SE 4.42%
BIIB
Biogen Inc. 4.40%

Sector Weightings

SectorBBH
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: BBH

Research Reports: BBH

  • VRSN: Raising target price to $201.00

    VERISIGN INC has an Investment Rating of HOLD; a target price of $201.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • Analyst Report: Vornado Realty Trust

    Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.

    Rating
    Price Target
     
  • RMBS: Raising target price to $67.00

    RAMBUS INC has an Investment Rating of HOLD; a target price of $67.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • VRSN: Lowering target price to $201.00

    VERISIGN INC has an Investment Rating of HOLD; a target price of $201.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     

Related Tickers